CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −2,400 | $45.01 | $108K | 132,411 |
| 2024-08-19 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −305 | $46.00 | $14K | 132,106 |
| 2024-06-11 | McNeill Jonathan Chief Business Officer | Sale | −1,823 | $31.34 | $57K | 134,811 |
| 2024-05-16 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −2,279 | $28.20 | $64K | 137,129 |
| 2024-05-16 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −495 | $28.59 | $14K | 136,634 |
| 2024-03-11 | McNeill Jonathan Chief Business Officer | Exercise or conversion 10b5-1 | +17,825 | $5.54 | $99K | 159,009 |
| 2024-03-11 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −17,825 | $25.48 | $454K | 141,184 |
| 2024-03-11 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −1,776 | $25.71 | $46K | 139,408 |
| 2024-03-11 | McNeill Jonathan Chief Business Officer | Exercise or conversion · Stock option (right to buy) 10b5-1 | −17,825 | 0 | ||
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Exercise or conversion 10b5-1 | +86,159 | $5.54 | $477K | 227,343 |
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Exercise or conversion 10b5-1 | +3,841 | $5.54 | $21K | 231,184 |
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −34,663 | $25.46 | $883K | 196,521 |
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −54,648 | $26.72 | $1.5M | 141,873 |
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −689 | $27.31 | $19K | 141,184 |
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Exercise or conversion · Stock option (right to buy) 10b5-1 | −86,159 | 12,309 | ||
| 2024-03-08 | McNeill Jonathan Chief Business Officer | Exercise or conversion · Stock option (right to buy) 10b5-1 | −3,841 | |||
| 2024-03-07 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −2,434 | $25.85 | $63K | 141,184 |
| 2024-03-01 | McNeill Jonathan Chief Business Officer | Exercise or conversion 10b5-1 | +24,260 | $0.73 | $18K | 167,878 |
| 2024-03-01 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −14,103 | $28.25 | $398K | 153,775 |
| 2024-03-01 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −8,715 | $29.06 | $253K | 145,060 |
Page 1 of 4 · 66 trades